Influenza-B Antibody

Influenza-B, Mouse Antibody
Cat. No.
BT8495
Source
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Hybridoma has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with purified influenza virus type B strain B/Tokio/53/99.

Product Specs

Introduction
Influenza-B virus, a genus within the Orthomyxoviridae virus family, encompasses a single species known as "Influenza B virus." This virus exhibits a restricted host range, primarily affecting humans and seals. Unlike Influenza virus A, which undergoes both genetic drift and reassortment, Influenza B virus's mutation process remains unclear. Notably, Influenza-B virus demonstrates a slower evolutionary rate compared to A viruses but a faster rate than C viruses, mutating at a rate 2-3 times lower than type A. Despite this slower mutation rate, lasting immunity to Influenza B is not achievable due to its constant evolution. The Influenza B virus possesses a capsid enveloped by a virion structure composed of a matrix protein, envelope, nucleoprotein complex, nucleocapsid, and a polymerase complex. Morphologically, Influenza B exhibits variability, appearing as both spherical and filamentous. Its approximately 500 surface projections consist of hemagglutinin and neuraminidase. The Influenza B virus genome comprises 14648 nucleotides, organized into eight linear, negative-sense, single-stranded RNA segments. This multipartite genome is encapsidated with each segment residing within a separate nucleocapsid, all of which are enveloped by a single membrane.
Description
This hybridoma cell line was generated by fusing Sp2/0 myeloma cells with spleen cells isolated from Balb/c mice. The Balb/c mice were immunized with a purified preparation of the influenza virus type B strain B/Tokio/53/99.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
The antibody is supplied in a solution of PBS at a pH of 7.4 and contains 0.1% sodium azide (NaN3) as a preservative.
Shipping Conditions
The antibody is shipped in liquid form and packaged with ice packs to maintain a cool temperature during transport.
Storage Procedures
The antibody should be stored at 4 degrees Celsius for extended periods.
Applications
This antibody is suitable for use in Western blotting and ELISA applications. It may also be employed in indirect immunofluorescence assays.
Purification Method
Protein-A column.
Type
Mouse Antibody Monoclonal.
Clone
PIB-633-HY.
Immunogen
Influenza-B.
Ig Subclass
mouse IgG1.

Product Science Overview

Influenza B

Influenza B is one of the four main types of influenza viruses, the others being Influenza A, C, and D. Unlike Influenza A, which can infect multiple species including birds and pigs, Influenza B is typically found only in humans and occasionally in seals . This limited host range is one reason why Influenza B has not caused pandemics, unlike its counterpart Influenza A .

Influenza B is responsible for a significant portion of seasonal flu cases, accounting for about 23% of influenza illnesses globally . It is highly contagious and can lead to severe respiratory symptoms such as coughing, congestion, and sore throat, as well as systemic symptoms like high fever, body aches, and fatigue . In some cases, it can cause serious complications like pneumonia, bronchitis, and even heart inflammation .

Mouse Antibodies

Mouse antibodies are antibodies derived from mice and have been extensively used in research and therapeutic applications. These antibodies are produced by immunizing mice with a specific antigen, which stimulates the mouse’s immune system to produce antibodies against that antigen . These antibodies can then be harvested and used for various purposes, including diagnostic tests and treatments for diseases.

One of the significant challenges with using mouse antibodies in humans is the Human Anti-Mouse Antibody (HAMA) response. This occurs when the human immune system recognizes the mouse antibodies as foreign and mounts an immune response against them . This can lead to reduced effectiveness of the treatment and potential allergic reactions . To mitigate this, researchers have developed techniques to humanize mouse antibodies, making them less likely to be recognized as foreign by the human immune system .

Influenza B and Mouse Antibodies

In the context of Influenza B, mouse antibodies can be used in research to study the virus and develop potential treatments. For example, researchers can create monoclonal antibodies from mice that target specific proteins on the Influenza B virus. These monoclonal antibodies can then be used to understand the virus’s behavior, identify potential drug targets, and develop vaccines.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.